Matthew A. Sills - Publications

Affiliations: 
1981-1984 Pharmacology University of Pennsylvania, Philadelphia, PA, United States 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1988 Bischoff S, Heinrich M, Krauss J, Sills MA, Williams M, Vassout A. Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome. Journal of Receptor Research. 8: 107-20. PMID 3290470 DOI: 10.3109/10799898809048981  0.31
1988 Sills MA, Mellow AM, Sunderland T, Jacobowitz DM. Central muscarinic cholinergic antagonists block wet-dog shakes produced by the TRH analog MK-771 in the rat. Brain Research. 453: 385-8. PMID 3135919  0.302
1988 Waldmeier PC, Williams M, Baumann PA, Bischoff S, Sills MA, Neale RF. Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 337: 609-20. PMID 2905765 DOI: 10.1007/BF00175785  0.35
1986 Sills MA, Heydorn WE, Cohen RM, Creed GJ, Jacobowitz DM. Effect of chronic treatment with clorgyline on the relative concentration of specific proteins in the hippocampus and parietal cortex of the rat. Neuropharmacology. 25: 143-50. PMID 3703169 DOI: 10.1016/0028-3908(86)90035-3  0.542
1986 Youdim MB, Sills MA, Heydorn WE, Creed GJ, Jacobowitz DM. Iron deficiency alters discrete proteins in rat caudate nucleus and nucleus accumbens. Journal of Neurochemistry. 47: 794-9. PMID 2942640 DOI: 10.1111/J.1471-4159.1986.Tb00681.X  0.547
1985 Sills MA, Lucki I, Frazer A. Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP. Life Sciences. 36: 2463-9. PMID 4010463 DOI: 10.1016/0024-3205(85)90142-0  0.569
1985 Frazer A, Lucki I, Sills M. Alterations in monoamine-containing neuronal function due to administration of antidepressants repeatedly to rats. Acta Pharmacologica Et Toxicologica. 56: 21-34. PMID 2984890 DOI: 10.1111/J.1600-0773.1985.Tb02496.X  0.543
1985 Sills MA, Lucki I, Frazer A. Development of selective behavioral tolerance following the repeated administration of serotonin agonists Federation Proceedings. 44: No. 4884.  0.508
1984 Sills MA, Wolfe BB, Frazer A. Multiple states of the 5-hydroxytryptamine1 receptor as indicated by the effects of GTP on [3H]5-hydroxytryptamine binding in rat frontal cortex. Molecular Pharmacology. 26: 10-8. PMID 6749126  0.483
1984 Sills MA, Wolfe BB, Frazer A. Determination of selective and nonselective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex. The Journal of Pharmacology and Experimental Therapeutics. 231: 480-7. PMID 6502510  0.502
1982 Hess ME, Prostran M, Carricato AM, Locke CL, Brzozowski C, Sills M, Viscusi D. Interaction between thyroxine and tricyclic antidepressant drugs on cardiac neurotransmitter receptors. Journal of Cardiovascular Pharmacology. 4: 856-62. PMID 6182419 DOI: 10.1097/00005344-198209000-00023  0.492
Show low-probability matches.